Engitix Therapeutics

0 followers

‌

To create a healthier future for patients with life-threatening diseases, Engitix Therapeutics is using its pioneering human extracellular matrix (ECM)-based discovery platform to develop a portfolio of programmes in fibrosis and solid tumors.

Industries

Headquarters

Stage

Employees

Links

Org chart

Giuseppe Mazza

CEO & Co-Founder

Giuseppe Mazza

Collapse

Chris Stevenson

Chief Scientific Officer

Alan Holmes

Vice President Fibrosis

Thomas Gobbetti

Liver Fibrosis Progamme Leader And Director Of Translational Biology / In Vivo

Lisa Longato

Director Biology

Amélie Fortin

Director, People & Culture

Calum MacLeod

Director Of Medicinal Chemistry

Luca Frenguelli

Director of Biomaterials

Amy Lewis

Director, Fibrosis

Athiva Shankar

Associate Director, Biospecimens & Tissue-Based Assays

Simran Sagoo

Accountant

Teams

+22

Science Team

25 members

Research and Development

6 members

Finance and Operations

3 members

Leadership Team

3 members

Similar companies

Oxford Nanopore Technologies

5 followers

Evaxion Biotech

6 followers

Summit Therapeutics

4 followers

Freenome

3 followers

Dermavant Sciences

3 followers

Premier Research

2 followers

AC Immune

2 followers

ADMA Biologics

2 followers

Autolus

1 follower

Keros Therapeutics

1 follower

Merus

1 follower

Discover companies